Behavioral
NPI deactivated
Minuteclinic LLC
Minuteclinic LLC was paid $14.00M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 39% of everything it billed.
33Billing provider infoMINUTECLINIC LLC
ROCKVILLE, MD 20854
ROCKVILLE, MD 20854
33aNPI1134191836assigned 02/06/2006
33bProvider typeClinical Social Worker
28Total paid$14.00M
24GClaims1,193,296
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Social Worker providers in Maryland
Rank by total paid#1 of 580
Median peer was paid$40K
This provider vs. median349×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,024 | $199K | |
| 2019 | 12,796 | $392K | |
| 2020 | 100,088 | $1.36M | |
| 2021 | 270,439 | $5.23M | |
| 2022 | 443,659 | $3.82M | |
| 2023 | 227,155 | $1.90M | |
| 2024incomplete | 134,135 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 39% | 352,161 | 258,933 | $5.52M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14% | 122,548 | 91,348 | $1.92M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.9% | 29,566 | 24,380 | $1.38M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.6% | 45,023 | 34,721 | $1.34M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.4% | 90,671 | 73,876 | $902K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.0% | 23,393 | 17,868 | $707K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.7% | 15,838 | 12,799 | $661K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 16,302 | 11,081 | $344K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 15,670 | 13,096 | $160K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 2,475 | 2,082 | $160K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 5,951 | 4,896 | $155K |
| 86580 | <1% | 8,907 | 6,886 | $88K |
79 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,761 | $74K |
| 99401 | <1% | 3,349 | $68K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15,159 | $62K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,673 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,194 | $37K |
| 90739 | <1% | 699 | $32K | |
| 90715 | <1% | 3,092 | $29K | |
| 90746 | <1% | 994 | $29K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,004 | $25K |
| 90716 | <1% | 850 | $22K | |
| 90674 | <1% | 3,608 | $22K | |
| 90651 | <1% | 438 | $19K | |
| 90686 | <1% | 2,552 | $19K | |
| 99201 | <1% | 597 | $13K | |
| 0071A | <1% | 495 | $11K | |
| 0001A | <1% | 628 | $11K | |
| 0081A | <1% | 874 | $10K | |
| 0072A | <1% | 393 | $9K | |
| 0082A | <1% | 591 | $9K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,751 | $8K |
| 81002 | <1% | 5,432 | $8K | |
| 0002A | <1% | 372 | $7K | |
| 0083A | <1% | 291 | $7K | |
| 90707 | <1% | 917 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 771 | $6K |
| 91320 | <1% | 146 | $6K | |
| 1036F | <1% | 75,275 | $6K | |
| 90661 | <1% | 203 | $5K | |
| 81025 | <1% | 2,039 | $5K | |
| 90480 | <1% | 460 | $5K | |
| 0004A | <1% | 288 | $5K | |
| 3074F | <1% | 66,488 | $4K | |
| 91322 | <1% | 183 | $4K | |
| 90632 | <1% | 112 | $3K | |
| 99402 | <1% | 150 | $3K | |
| 0031A | <1% | 67 | $3K | |
| 0121A | <1% | 134 | $2K | |
| 90713 | <1% | 215 | $2K | |
| 90682 | <1% | 185 | $2K | |
| 90619 | <1% | 201 | $1K | |
| 0124A | <1% | 76 | $1K | |
| 3008F | <1% | 64,906 | $1K | |
| 90656 | <1% | 102 | $1K | |
| 90714 | <1% | 94 | $1K | |
| 0052A | <1% | 152 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,192 | $1K |
| 90734 | <1% | 122 | $977.12 | |
| 0154A | <1% | 29 | $849.52 | |
| 0074A | <1% | 74 | $758.57 | |
| 0051A | <1% | 128 | $754.78 | |
| 86328 | <1% | 65 | $636.26 | |
| 0171A | <1% | 18 | $626.91 | |
| 87905 | <1% | 135 | $543.93 | |
| G0008 | Administration of influenza virus vaccine | <1% | 95 | $488.47 |
| 1160F | <1% | 49,757 | $443.60 | |
| 91321 | <1% | 52 | $441.12 | |
| 0173A | <1% | 17 | $399.25 | |
| 90700 | <1% | 40 | $310.70 | |
| 1159F | <1% | 48,886 | $300.00 | |
| 3078F | <1% | 56,898 | $150.00 | |
| 90694 | <1% | 17 | $138.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $135.64 |
| 3079F | <1% | 12,873 | $125.00 | |
| 86308 | <1% | 86 | $90.83 | |
| 3077F | <1% | 2,002 | $75.00 | |
| 3080F | <1% | 1,692 | $50.00 | |
| 3075F | <1% | 4,614 | $50.00 | |
| 91308 | <1% | 1,104 | $40.01 | |
| 91307 | <1% | 295 | $40.00 | |
| 82947 | <1% | 23 | $14.79 | |
| 91305 | 0% | 248 | $0.00 | |
| 91301 | 0% | 18 | $0.00 | |
| 1000F | 0% | 50 | $0.00 | |
| 91315 | 0% | 31 | $0.00 | |
| 91300 | 0% | 505 | $0.00 | |
| 91312 | 0% | 237 | $0.00 | |
| 4120F | 0% | 135 | $0.00 | |
| 4124F | 0% | 330 | $0.00 | |
| 90710 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPINCINCE, DEBORAH (ADMINISTRATOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.